Ashton Thomas Private Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$270K Buy
923
+266
+40% +$87.4K 0.01% 929
2025
Q4
$230K Buy
657
+35
+6% +$11.8K 0.01% 915
2025
Q3
$201K Sell
622
-2,365
-79% -$736K 0.01% 938
2025
Q2
$1.16M Buy
+2,987
New +$1.2M 0.04% 379
2024
Q3
Sell
-263
Closed -$142K 972
2024
Q2
$142K Buy
+263
New +$139K 0.01% 662
2023
Q2
Sell
-563
Closed -$259K 578
2023
Q1
$259K Sell
563
-23
-4% -$10.9K 0.02% 444
2022
Q4
$301K Buy
586
+73
+14% +$37.1K 0.03% 396
2022
Q3
$233K Buy
513
+6
+1% +$2.87K 0.03% 421
2022
Q2
$245K Buy
+507
New +$251K 0.03% 406

Other funds holding ELV

Ashton Thomas Private Wealth's ELV Position: Q1 2026 in Review

Ashton Thomas Private Wealth increased its Elevance Health (ELV) stake by 40% in Q1 2026, buying an estimated $87.4K and bringing the position to 923 shares worth $270K. The position accounts for 0.01% of the portfolio, ranked #929.

Ashton Thomas Private Wealth first reported a position in ELV in Q2 2022 and has held it in 9 quarters since. The position peaked at $1.16M in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Ashton Thomas Private Wealth held 923 shares of Elevance Health worth $270K as of Q1 2026.
  • Ashton Thomas Private Wealth bought 266 Elevance Health shares in Q1 2026, an estimated $87.4K.
  • Elevance Health made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q1 2026, its #929 holding.
  • Ashton Thomas Private Wealth first reported a position in Elevance Health in Q2 2022 and has held it in 9 quarters since.
  • Ashton Thomas Private Wealth's Elevance Health position peaked at $1.16M in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2026, filed 11 May 2026.